Loss-of-function mutations ensure that response to immune checkpoint therapy is NOD2 be denied 5 de September de 2025 by Ana C. Anderson and Manu Rangachari Science Immunology, Volume 10, Issue 111, September 2025.
Ana C. Anderson and Manu Rangachari